GLAXO INC has a total of 316 patent applications. Its first patent ever was published in 1988. It filed its patents most often in United States, United Kingdom and South Africa. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SANOFI WINTHROP INC, LILLY CO ELI and HOFFMANN LA ROCHE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 53 | |
#2 | United Kingdom | 34 | |
#3 | South Africa | 23 | |
#4 | WIPO (World Intellectual Property Organization) | 21 | |
#5 | Australia | 19 | |
#6 | Canada | 17 | |
#7 | Israel | 16 | |
#8 | EPO (European Patent Office) | 11 | |
#9 | Japan | 11 | |
#10 | China | 10 | |
#11 | Mexico | 9 | |
#12 | New Zealand | 7 | |
#13 | Taiwan | 7 | |
#14 | Finland | 6 | |
#15 | Ireland | 6 | |
#16 | Iceland | 6 | |
#17 | Peru | 5 | |
#18 | Norway | 4 | |
#19 | Malaysia | 3 | |
#20 | Philippines | 3 | |
#21 | Portugal | 3 | |
#22 | African Regional Industrial Property Organization | 2 | |
#23 | Austria | 2 | |
#24 | Belgium | 2 | |
#25 | Switzerland | 2 | |
#26 | Czechia | 2 | |
#27 | Germany | 2 | |
#28 | Denmark | 2 | |
#29 | Ecuador | 2 | |
#30 | France | 2 | |
#31 | Hungary | 2 | |
#32 | Republic of Korea | 2 | |
#33 | Sweden | 2 | |
#34 | Slovenia | 2 | |
#35 | Slovakia | 2 | |
#36 | Brazil | 1 | |
#37 | Cyprus | 1 | |
#38 | Spain | 1 | |
#39 | Greece | 1 | |
#40 | Hong Kong | 1 | |
#41 | India | 1 | |
#42 | Italy | 1 | |
#43 | Morocco | 1 | |
#44 | Netherlands | 1 | |
#45 | African Intellectual Property Organization | 1 | |
#46 | Poland | 1 | |
#47 | Saudi Arabia | 1 | |
#48 | Singapore | 1 | |
#49 | Tunisia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Packaging and shipping | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Syringes | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Steroids | |
#8 | Containers for goods storage | |
#9 | Unspecified technologies | |
#10 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Luzzio Michael Joseph | 26 |
#2 | Myers Peter Leslie | 25 |
#3 | Evans Michael G | 24 |
#4 | Besterman Jeffrey M | 22 |
#5 | Frye Stephen Vernon | 20 |
#6 | Palson Richard Charles Julius | 17 |
#7 | Armstrong John Creighton | 16 |
#8 | Shaffer Joel E | 15 |
#9 | Wheeler Thomas N | 15 |
#10 | Feldman Paul L | 14 |
Publication | Filing date | Title |
---|---|---|
IL113366D0 | 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them | |
GB9506678D0 | Substituted 6-azacholesten-3-ones | |
GB9506680D0 | Heterocycle-substituted pyrrolidines | |
GB9506282D0 | Antagonists of A-1C adrenergic receptors | |
GB9505031D0 | Nonamide inibitors of human PLA2 having a sulfone group at SN-2 position | |
GB9504991D0 | Nonamide inhibitors of human synovial phospholipase a | |
GB9505007D0 | Amide phospholipid-like compounds as drug absorption enhancers | |
GB9505006D0 | Amide inhibitors of human synovial phospholipase a2 | |
GB9423635D0 | Quinazoline antagonists of alpha 1c adrenergic receptors | |
GB9423670D0 | Antagonists of a- 1c adrenergic receptors | |
GB9423638D0 | Antagonists of a- 1c adrenergic receptors | |
GB9423680D0 | Antagonists of a- 1c adrenergic receptors | |
GB9420702D0 | Heterocyclic compounds | |
GB9420747D0 | 1,5 benzodiazepine derivatives | |
GB9420755D0 | Heterocyclic derivatives | |
GB9420763D0 | Acetamide derivatives | |
GB9420783D0 | Heterocyclic derivatives | |
GB9420748D0 | 1,5 benzodiazepine derivatives | |
GB9420699D0 | Medicaments | |
GB9420700D0 | Heterocyclic compounds |